Lexicon Pharmaceuticals LXRX Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's preferred stock, par or stated value per share?
- Lexicon Pharmaceuticals (LXRX) reported preferred stock, par or stated value per share of $0.01 in Q1 2026.
- How has Lexicon Pharmaceuticals's preferred stock, par or stated value per share changed year-over-year?
- Lexicon Pharmaceuticals's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Lexicon Pharmaceuticals's preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.